Expression of the COVID‐19 receptor ACE2 in the human conjunctiva

SARS‐CoV‐2 is assumed to use angiotensin‐converting enzyme 2 (ACE2) and other auxiliary proteins for cell entry. Recent studies have described conjunctival congestion in 0.8% of patients with laboratory‐confirmed severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), and there has been specul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Clemens, Wolf, Julian, Auw‐Haedrich, Claudia, Schlecht, Anja, Boneva, Stefaniya, Lapp, Thabo, Horres, Ralf, Agostini, Hansjürgen, Martin, Gottfried, Reinhard, Thomas, Schlunck, Günther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267303/
https://www.ncbi.nlm.nih.gov/pubmed/32374427
http://dx.doi.org/10.1002/jmv.25981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267303/
https://www.ncbi.nlm.nih.gov/pubmed/32374427
http://dx.doi.org/10.1002/jmv.25981

Ejemplares similares